Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

P083 Clinical progression of SARS-CoV-2 infection in people with cystic fibrosis: a global observational study

Autor: McClenaghan, E., Cosgriff, R., Brownlee, K., Ahern, S., Burgel, P.-R., Byrnes, C.A., Colombo, C., Corvol, H., Cheng, S.Y., Daneau, G., Elbert, A., Faro, A., Goss, C.H., Gulmans, V., Gutierrez, H., de Monestrol, I., Jung, A., Nährlich, L., Kashirskaya, N., Marshall, B.C., McKone, E., Middleton, P.G., Mondejar-Lopez, P., Pastor-Vivero, M.D., Padoan, R., Rizvi, S., Ruseckaite, R., Salvatore, M., Stephenson, A.L., da Silva Filho, L.V.R., Melo, J., Zampoli, M., Abdrakhmanov, O., Harutyunyan, S., Carr, S.B.

Publikováno v: In Journal of Cystic Fibrosis 2021 20 Supplement 1:S65-S65

Motor performance and disability in Dutch children with haemophilia: a comparison with their healthy peers.

Autor: Schoenmakers, M. A. G. C.¹, Gulmans, V. A. M.¹, Helders, P. J. M.¹, Van Den Berg, H. M.²

Publikováno v: Haemophilia. May2001, Vol. 7 Issue 3, p293-298. 6p. 6 Charts.

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

Cost-effectiveness of newborn screening for cystic fibrosis determined with real-life data

Autor: van der Ploeg, C. P B, van den Akker-van Marle, M. E., Vernooij-van Langen, A. M M, Elvers, L. H., Gille, J. J P, Verkerk, P. H., Dankert-Roelse, J. E., Loeber, J. G., Triepels, R. H., Van der Ploeg, C. P B, van der Pal, S. M., Dompeling, E., Pals, G., van den Akker van Marle, M. E., Gulmans, V. A M, Oey-Spauwen, M. J W, Wijnands, Y. H H M, Castricum, L. M., Arets, H. G M, van der Ent, C. K., Tiddens, H. A W M, de Rijke, Y. B., Yntema, J. B.

Publikováno v: Journal of Cystic Fibrosis, 14(2), 194-202
van der Ploeg, C P B, van den Akker-v Marie, ME, Vernooij-van Langen, A M M, Elvers, L H, Gille, J J P, Verkerk, P H & Dankert-Roelse, J E 2015, ' Cost-effectiveness of newborn screening for cystic fibrosis determined with real-life data ', Journal of Cystic Fibrosis, vol. 14, no. 2, pp. 194-202 . https://doi.org/10.1016/j.jcf.2014.08.007
Journal of Cystic Fibrosis, 14(2), 194. Elsevier
Journal of Cystic Fibrosis, 14(2), 194-202. Elsevier Science
Journal of Cystic Fibrosis, 14(2), 194-202. Elsevier

Background: Previous cost-effectiveness studies using data from the literature showed that newborn screening for cystic fibrosis (NBSCF) is a good economic option with positive health effects and longer survival. Methods: We used primary data to comp

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::25cbac0fa3ee8eb5c4763af31dde60ea
http://hdl.handle.net/1887/108027